Science & Technology
FY2024 CDC/NCIRD SBIR 036-Improved Diagnostic Assays for Measles, Mumps, Rubella, and Varicella
Department of Health and Human Services — Centers for Disease Control and Prevention
Opportunity #: 200-2024-20096
Award Ceiling
$243K
Award Floor
$243K
Close Date
N/A
Total Funding
$243K
Expected Awards
1
Cost Sharing Required
No
Grants.gov ID
sbir-200-2024-20096
Description
SBIR Phase Phase I award: "FY2024 CDC/NCIRD SBIR 036-Improved Diagnostic Assays for Measles, Mumps, Rubella, and Varicella" awarded to MIFI, LLC in Stillwater, Oklahoma. Funded by Department of Health and Human Services (Centers for Disease Control and Prevention). Award amount: $242,905. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses, HUBZone businesses, Women-owned businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.